MOLECULIN BIOTECH INC's ticker is MBRX and the CUSIP is 60855D200. A total of 23 filers reported holding MOLECULIN BIOTECH INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 271,230 | $115,951 | 0.04% |
| SCHMIDT P J INVESTMENT MANAGEMENT INC | 29,000 | $17,835 | 0.00% |
| JMAC ENTERPRISES LLC | 13,132 | $5,614 | 0.00% |
| VANGUARD GROUP INC | 1,080,122 | $461,753 | 0.00% |
| UBS Group AG | 200 | $85 | 0.00% |
| OSAIC HOLDINGS, INC. | 968 | $414 | 0.00% |
| FMR LLC | 2 | $1 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 100 | $43 | 0.00% |
| WELLS FARGO & COMPANY/MN | 717 | $307 | 0.00% |
| NORTHERN TRUST CORP | 53,596 | $22,912 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 246,670 | $105,484 | 0.00% |
| STATE STREET CORP | 71,397 | $30,522 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 30,493 | $13,036 | 0.00% |
| NBC SECURITIES, INC. | 200 | $0 | 0.00% |
| North Star Investment Management Corp. | 250 | $107 | 0.00% |
| MORGAN STANLEY | 6,334 | $2,708 | 0.00% |
| BlackRock Inc. | 196,298 | $83,918 | 0.00% |
| Sigma Planning Corp | 17,000 | $7,268 | 0.00% |
| Tower Research Capital LLC (TRC) | 14,305 | $6,123 | 0.00% |
External links
This page lists MOLECULIN BIOTECH INC's shareholders in Q3 2023. To view MOLECULIN BIOTECH INC's shareholder history, click here.